Literature DB >> 3040884

Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus.

H Volkmer, C Bertholet, S Jonjić, R Wittek, U H Koszinowski.   

Abstract

The murine immediate-early (IE) protein pp89 is a nonstructural virus-encoded phosphoprotein residing in the nucleus of infected cells, where it acts as transcriptional activator. Frequency analysis has shown that in BALB/c mice the majority of virus-specific CTL recognize IE antigens. The present study was performed to assess whether pp89 causes membrane antigen expression detected by IE-specific CTL. Site-directed mutagenesis has been used to delete the introns from gene ieI, encoding pp89, for subsequent integration of the continuous coding sequence into the vaccinia virus genome. After infection with the vaccinia recombinant, the authentic pp89 was expressed in cells that became susceptible to lysis by an IE-specific CTL clone. Priming of mice with the vaccinia recombinant sensitized polyclonal CTL that recognized MCMV-infected cells and transfected cells expressing pp89. Thus, a herpesviral IE polypeptide with essential function in viral transcriptional regulation can also serve as a dominant antigen for the specific CTL response of the host.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040884      PMCID: PMC2188685          DOI: 10.1084/jem.166.3.668

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection.

Authors:  G M Keil; A Ebeling-Keil; U H Koszinowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

4.  The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors.

Authors:  M J Reddehase; G M Keil; U H Koszinowski
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

5.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

6.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones.

Authors:  A E Campbell; F L Foley; S S Tevethia
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Physical mapping of vaccinia virus temperature-sensitive mutations.

Authors:  R Drillien; D Spehner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.

Authors:  M J Reddehase; G M Keil; U H Koszinowski
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

View more
  30 in total

1.  The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Authors:  K Schwarz; R de Giuli; G Schmidtke; S Kostka; M van den Broek; K B Kim; C M Crews; R Kraft; M Groettrup
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

2.  Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Authors:  M Del Val; H J Schlicht; H Volkmer; M Messerle; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Recent progress in cytomegalovirus research.

Authors:  J D Benson; E S Huang
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

4.  Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.

Authors:  L D Cranmer; C L Clark; C S Morello; H E Farrell; W D Rawlinson; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  DNA immunization confers protection against murine cytomegalovirus infection.

Authors:  J C González Armas; C S Morello; L D Cranmer; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

7.  Site-directed mutagenesis in the active site of the herpes simplex virus type 1 thymidine kinase gene.

Authors:  J Fetzer; G Folkers; I Müller; G M Keil
Journal:  Virus Genes       Date:  1993-06       Impact factor: 2.332

8.  The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon.

Authors:  Daniel M Andrews; Christopher E Andoniou; Peter Fleming; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2.

Authors:  Steffen Krauss; Julia Kaps; Nathalie Czech; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

10.  Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3.

Authors:  M Messerle; B Bühler; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.